Biotech Market Watch: Phathom Posts Earnings Beat While Medicus Holds Steady
Indonesia Launches Locally Produced Cancer Therapies in Collaboration with BeiGene
MindMed Advances Clinical Pipeline in Brain Health Treatment
ABL Bio and GSK Partner to Develop Treatments for Neurodegenerative Diseases Using Grabody-B Platform
Okeiro Raises €10 Million to Expand AI-Driven Precision Medicine Platform for Transplantation and Chronic Diseases
Palmas Strengthens Public Healthcare with Investments in Infrastructure, Medications, and Staffing
Deutsche Bahn Shifts Focus: Kiosk Brand “ServiceStore DB” to Be Phased Out by 2026
Universe Pharmaceuticals Stock Plunges to 52-Week Low Amid Mounting Challenges
Hyundai Insteroid: A Video Game Dream on Wheels
DAX Rebounds as Investors Shake Off Tariff Fears
Phathom Pharma Exceeds Expectations Phathom Pharma recently delivered a solid earnings surprise, beating EPS estimates by $0.34 and topping revenue forecasts. The stock closed regular
PT Etana Biotechnologies Indonesia has officially introduced two new cancer treatment drugs—Etapidi (tislelizumab) and Brukinsa (zanubrutinib)—marking a significant milestone in the country’s healthcare landscape. The
Mind Medicine (MindMed) Inc., a clinical-stage biopharmaceutical company based in New York City, continues its mission to develop innovative therapies for brain health disorders. Founded
ABL Bio Inc. (KOSDAQ: 298380), a biotechnology company specializing in bispecific antibodies for immuno-oncology and neurodegenerative diseases, has announced a global licensing agreement with pharmaceutical
Okeiro, a French company specializing in precision medicine for transplantation and advanced chronic diseases, has announced a €10 million funding round to support its growth
In the first 100 days of the new administration, the Palmas City Hall has made healthcare one of its top priorities. Under the leadership of
Deutsche Bahn (DB) has announced its decision to exit the kiosk business at German train stations, marking another step in its ongoing modernization strategy. The
Universe Pharmaceuticals Inc. is facing increasing financial pressure as its stock has dropped to a new 52-week low of just $3.20. The sharp decline reflects
Hyundai has unveiled a bold new design concept called the Insteroid, transforming its modest compact EV, the Inster, into a futuristic fusion of race car
After several weaker sessions, investors returned to the Frankfurt Stock Exchange today with renewed confidence. The DAX index made solid gains, overcoming recent concerns about
